Clinical Trials Logo

Adrenal Gland Diseases clinical trials

View clinical trials related to Adrenal Gland Diseases.

Filter by:

NCT ID: NCT02618694 Completed - Pheochromocytoma Clinical Trials

Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study

PostLapAdrnl
Start date: April 2015
Phase: N/A
Study type: Interventional

This randomized comparative study assesses the safety and efficacy of the posterior retroperitoneoscopic adrenalectomy in comparison to the standard, anterior transperitoneal approach and suppose that this new technique is a safe and effective alternative to the standard approach.

NCT ID: NCT01676025 Completed - Adrenal Disease Clinical Trials

Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy

PRA
Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to compare two surgical methods of adrenalectomy. One is called PRA(posterior retroperitoneal adrenalectomy), which is performed through 3 or 4 holes at patient's back. The other is LA(laparoscopic adrenalectomy) which is performed through patient's abdominal cavity after making 3 or 4 holes in the abdomen.

NCT ID: NCT00721929 Completed - Clinical trials for Adrenal Gland Disease

Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

Start date: October 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if certain MRI sequences can accurately diagnose adrenal masses of unknown origin.

NCT ID: NCT00037843 Completed - Clinical trials for Adrenal Gland Neoplasms

Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening

Start date: December 1988
Phase: Phase 3
Study type: Interventional

This is a clinical research study using I-131 Iodocholesterol which is an experimental radioactive chemical that when injected into the vein, is picked up in the adrenal glands and permits visualization with gamma imaging devices. These images are used in diagnosing a variety of adrenal abnormalities.Prior to the injection of I-131 Iodocholesterol, the patient will receive perchlorate capsules to block any uptake of I-131 by the thyroid gland if this is deemed important. The patient will continue to take these capsules throughout the period of imaging, which may last up to 1 week. The injection of I-131 Iodocholesterol will be given into a vein and the patient will return for images on at least 1 and possibly 2 occasions between 3-7 days after injection. If the case requires it, the patient may also be given a steroid in tablet form, dexamethasone, to take orally prior to and after the injection to suppress normal adrenal function so that the abnormal tissues can be more easily detected.